DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN'S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY

被引：0
|
作者：
Bertani, L. [1 ]
Ferraro, S. [1 ]
Bartolini, C. [2 ]
Convertino, I [1 ]
Giometto, S. [1 ]
Cappello, E. [1 ]
Valdiserra, G. [1 ]
Tillati, S. [1 ]
Blandizzi, C. [1 ]
Lucenteforte, E. [1 ]
Gini, R. [2 ]
Tuccori, M. [3 ]
Costa, F. [3 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] ARS, Tuscan Reg Hlthcar Agcy, Florence, Italy
[3] Pisa Univ Hosp, Pisa, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2021年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AF.58
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [41] Systematic Literature Review of Real-World Effectiveness and Safety of Vedolizumab in Adult Ulcerative Colitis and Crohn's Disease Patients
    Demuth, Dirk
    Bovens, Sandra
    Solaman, Angela
    Curtis, Rebecca
    O'Byrne, Sharon
    Khalid, Javaria Mona
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S298 - S298
  • [42] REAL-WORLD EFFICACY AND SAFETY OF SECUKINUMAB: DATA FROM VERONA'S COHORT
    Martinis, F.
    Caimmi, C.
    Carletto, A.
    Fracassi, E.
    Rossini, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1544 - 1545
  • [43] Real-world data on the treatment with Upadacitinib in a biological-experienced Crohn's disease cohort
    Kubesch, A.
    Lande, R.
    Farrag, K.
    Jungheim, F.
    Dienethal, A.
    Sprinzl, K.
    Zeuzem, S.
    Blumenstein, I.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1944 - I1944
  • [44] Real-world effectiveness and safety of risankizumab in patients with moderate-to-severe multi-refractory Crohn's disease: a Belgian multicentric cohort study
    Alsoud, D.
    Franchimont, D.
    D'Heygere, F.
    Bossuyt, P.
    Vijverman, A.
    Van Hootegem, P.
    Sabino, J.
    Cremer, A.
    Vermeire, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I516 - I517
  • [45] Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn's disease: A Belgian multi-centric refractory cohort
    Pavlidi, A.
    Verstockt, B.
    Vieujean, S.
    Desmedt, V
    Couturier, F.
    Rahier, J. F.
    Baert, F.
    Somers, M.
    Dewit, O.
    Bossuyt, P.
    Hoyois, A.
    Holvoet, T.
    Ouziel, R.
    Willandt, B.
    Lambrecht, G.
    Salame, M.
    Verreth, A.
    Lenfant, M.
    Franchimont, D.
    Cremer, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1776 - i1777
  • [46] Efficacy and safety of ustekinumab in Crohn's disease: A real-world study from Australia
    Ramaswamy, P. Kakkadasam
    Moattar, H.
    Sawyer, E.
    Edwards, J.
    Shukla, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S564 - S565
  • [47] Early Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Single-Center Study
    Liu, Esther
    Mandel, Jordan
    Battat, Robert
    Longman, Randy
    Scherl, Ellen
    Lukin, Dana
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S759 - S760
  • [48] Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
    Engel, Tal
    Yung, Diana E.
    Ma, Christopher
    Pariente, Benjamin
    Wils, Pauline
    Eliakim, Rami
    Ungar, Bella
    Ben-Horin, Shomron
    Kopylov, Uri
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1232 - 1240
  • [49] Real-World Outcomes of Upadacitinib in Crohn's Disease: Insights from ENEIDA database
    Iborra, M.
    Botella, B.
    Martin-Arranz, M. D.
    Ceballos, D.
    Martinez-Pascual, C.
    Ripoll, P.
    Varela, P.
    Moreta, M.
    Montserrat, A.
    Gonzalez-Lama, Y.
    Rodriguez-Gonzalez, E.
    Vicuna, M.
    Gisbert, J. P.
    Ordas, I
    Argueelles-Arias, F.
    Tosca, J.
    Vicente, R.
    Sierra, M.
    Rodriguez-Lago, I
    Martin-Rodriguez, D.
    Paredes, J. M.
    Sicilia, B.
    Garcia de la Filia, I
    Jimenez, N.
    Barreiro de Acosta, M.
    Betore, E.
    Ferrer, I
    Garcia-Alles, L.
    Huguet, J. M.
    Castellet, S.
    Garcia, M. J.
    Gutierrez, A.
    Ponferrada, A.
    Ramos, L.
    Calafat, M.
    Domenech, E.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1688 - i1689
  • [50] Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
    Lorenzo Gonzalez, Laura
    Valdes Delgado, Teresa
    Vazquez Moron, Juan Maria
    Castro Laria, Luisa
    Leo Carnerero, Eduardo
    Maldonado Perez, Maria Belen
    Sanchez Capilla, Damian
    Pallares Manrique, Hector
    Saez Diaz, Antonia
    Arguelles Arias, Federico
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (05) : 272 - 279
12345